Pro-Dex, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $201.2M
- Price
- $62.80
- % Change (Daily % change from the live per-ticker quote feed.)
- -3.27%
- Volume
- 53.6K
About
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Quick stats
Shares outstanding3.2M
Computed float1.7M
Float / shares53.3%
Key info
SectorHealthcare
IndustryMedical - Instruments & Supplies
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000788920
Websitehttps://www.pro-dex.com
AI Summary
AI-generated1/6
majorbullishearnings
Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results
Pro-Dex (PDEX) closed fiscal 2026 with fourth-quarter net sales of $20.4 million, up 17% year-over-year, driven primarily by its largest customer's next-generation orthopedic handpiece.
Q4 gross margin expanded from 20% to 35%, lifting operating income 163% to $3.5 million and diluted EPS to $0.87 from $0.36. Full-year sales rose 16% to $77.5 million with net income of $13.7 million, or $4.12 per diluted share, versus $2.67 last year.
Earnings quality caveats: FY26 net income includes $5.7 million of gains on marketable equity investments, and the company booked a $349,000 allowance for uncollectible receivables. Operating cash flow swung to $7.2 million and cash ended at $8.2 million following the February 9, 2026 acquisition of Advanced Precision Machining (APM).
Red flags
- FY26 net income includes $5.7M of gains on marketable equity investments -- non-operating and management notes valuations can be highly volatile
- Heavy customer concentration: largest customer accounted for $15.3M of the FY revenue increase, while repair revenue from that same customer fell $6.0M
- $349,000 allowance for uncollectible receivables booked during the year (allowance was $0 a year earlier)
- Accounts receivable grew to $21.2M from $16.4M, outpacing 16% sales growth
- No forward guidance provided in the release